OPPTF
REGN icon

OPSEU Pension Plan Trust Fund’s Regeneron Pharmaceuticals REGN Stock Holding History

OPSEU Pension Plan Trust Fund’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,048
Closed -$3.68M – 224
2022
Q3 		$3.68M Buy
5,048
+42
+0.8% +$26.4K 0.97% 8
2022
Q2 		$2.94M Buy
5,006
+3,138
+168% +$2.04M 0.74% 16
2022
Q1 		$1.3M Buy
1,868
+67
+4% +$42.4K 0.31% 148
2021
Q4 		$1.12M Buy
1,801
+36
+2% +$22.1K 0.25% 172
2021
Q3 		$1M Sell
1,765
-87
-5% -$54K 0.25% 175
2021
Q2 		$1.09M Buy
1,852
+114
+7% +$57.8K 0.28% 164
2021
Q1 		$819K Buy
1,738
+61
+4% +$29.7K 0.21% 197
2020
Q4 		$817K Buy
1,677
+186
+12% +$100K 0.23% 186
2020
Q3 		$827K Buy
1,491
+34
+2% +$20.6K 0.26% 167
2020
Q2 		$896K Buy
1,457
+890
+157% +$505K 0.31% 136
2020
Q1 		$274K Buy
+567
New +$234K 0.11% 272

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OPSEU Pension Plan Trust Fund's REGN Position: Q4 2022 in Review

OPSEU Pension Plan Trust Fund sold out of Regeneron Pharmaceuticals (REGN) in Q4 2022, closing a stake of 5,048 shares — an estimated $3.68M sold.

OPSEU Pension Plan Trust Fund first reported a position in REGN in Q1 2020 and held it in 11 quarters. The position peaked at $3.68M in Q3 2022. 1,158 funds tracked by Wall St. Rank hold REGN as of Q4 2022.

  • OPSEU Pension Plan Trust Fund reported no remaining Regeneron Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • OPSEU Pension Plan Trust Fund sold 5,048 Regeneron Pharmaceuticals shares in Q4 2022, an estimated $3.68M.
  • OPSEU Pension Plan Trust Fund first reported a position in Regeneron Pharmaceuticals in Q1 2020 and held it in 11 quarters.
  • OPSEU Pension Plan Trust Fund's Regeneron Pharmaceuticals position peaked at $3.68M in Q3 2022.
  • 1,158 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2022.

Based on OPSEU Pension Plan Trust Fund's 13F filing for Q4 2022, filed 9 Feb 2023.